Cardiac fibroblasts in cell culture systems: myofibroblasts all along?

Stephan Rohr1

  • 1Department of Physiology, University of Bern, Bern, Switzerland. rohr@pyl.unibe.ch

Insights

Cardiac fibroblasts and myofibroblasts interact electrically and via paracrine signaling with cardiomyocytes. Understanding this crosstalk is crucial for cardiac health, but requires better research methods for intact tissues.

Area of Science:

  • Cardiovascular Biology
  • Cellular Interactions
  • Cardiac Fibroblast Research

Background:

  • The working myocardium comprises cardiomyocytes and fibroblasts, with fibroblasts vital for extracellular matrix structure.
  • Interactions between cardiac fibroblasts and cardiomyocytes, including paracrine and electrotonic signaling, are not fully understood.
  • In vivo cell intermingling hinders direct investigation of heterocellular crosstalk.

Purpose of the Study:

  • To review recent insights into electrical and paracrine crosstalk between myofibroblasts and cardiomyocytes.
  • To highlight the limitations of current culture systems in studying fibroblast-cardiomyocyte interactions.
  • To emphasize the need for improved methodologies for investigating cell crosstalk in intact cardiac tissue.

Main Methods:

  • Review of current literature on cardiac fibroblast and myofibroblast interactions with cardiomyocytes.
  • Analysis of cell culture system limitations, particularly the fibroblast-to-myofibroblast phenotype switch.
  • Discussion of challenges in studying in vivo heterocellular crosstalk.

Main Results:

  • Cardiac fibroblasts exhibit a phenotype switch to myofibroblasts in 2D culture, mimicking injured heart conditions.
  • Myofibroblasts engage in electrical and paracrine crosstalk with cardiomyocytes, influencing fibrotic remodeling.
  • Current research methods limit the direct investigation of these interactions in their native context.

Conclusions:

  • Understanding myofibroblast-cardiomyocyte crosstalk is essential for comprehending cardiac fibrotic remodeling.
  • Future research requires methodologies that maintain fibroblast phenotype in culture and enable in vivo crosstalk studies.
  • Advancements in studying heterocellular crosstalk are critical for developing targeted cardiac therapies.